Crossroads: The role of biomarkers in the management of lumps in the breast
A new research perspective was published in Oncotarget's, titled "Crossroads: the role of biomarkers in the management of lumps in the breast."
May 2, 2023
0
12
A new research perspective was published in Oncotarget's, titled "Crossroads: the role of biomarkers in the management of lumps in the breast."
May 2, 2023
0
12
Chronic inflammation is a predisposing condition for colorectal cancer, the third leading cause of cancer-related deaths in the United States.
Jul 6, 2018
0
4
In an article published September 22, 2016 in Frontiers in Immunology, researchers at the Medical University of South Carolina (MUSC) and the Ralph H. Johnson VA Medical Center report that inhibiting prostaglandin production ...
Nov 30, 2016
0
1
Working with tissue, blood and DNA from six people with precancerous and cancerous lung lesions, a team of Johns Hopkins scientists has identified what it believes are among the very earliest "premalignant" genetic changes ...
Sep 21, 2015
0
133
(Medical Xpress)—A first-of-its-kind vaccine developed by University of Pittsburgh Cancer Institute (UPCI) researchers successfully prompted the immune system to respond to early indications of colon cancer in people at ...
Jan 8, 2013
0
1
A diagnosis of pancreatic cancer is particularly devastating since the prognosis for recovery is usually poor, with the cancer most often not detected until late stages.
Nov 29, 2012
0
2
A group of molecular markers have been identified that can help clinicians determine which patients with low-grade oral premalignant lesions are at high risk for progression to oral cancer, according to data from the Oral ...
Aug 21, 2012
0
0